Literature DB >> 27693924

Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.

Amy C Doty1, Keiji Hirota1, Karl F Olsen1, Naoya Sakamoto2, Rose Ackermann1, Meihua R Feng1, Yan Wang3, Stephanie Choi3, Wen Qu3, Anna Schwendeman1, Steven P Schwendeman4.   

Abstract

Here we describe development of a silicone rubber/stainless steel mesh cage implant system, much like that used to assess biocompatibility of biomaterials [1], for easy removal of injectable polymer microspheres in vivo. The sterile cage has a type 316 stainless steel mesh size (38 μm) large enough for cell penetration and free fluid flow in vivo but small enough for microsphere retention, and a silicone rubber shell for injection of the microspheres. Two model drugs, the poorly soluble steroid, triamcinolone acetonide, and the highly water-soluble luteinizing hormone-releasing hormone (LHRH) peptide superagonist, leuprolide, were encapsulated in PLGA microspheres large enough (63-90 μm) to be restrained by the cage implant in vivo. The in vitro release from both formulations was followed by ultra-performance liquid chromatography (UPLC) with and without the cage in a standard release media, PBS pH 7.4 + 0.02% Tween 80 + 0.05% sodium azide, at 37 °C. Pharmacokinetics (PK) in rats was assessed after SC injection or SC in-cage implantation of microspheres with plasma analysis by LC-MS/MS or EIA. Tr-A and leuprolide in vitro release was largely unaffected after the initial burst irrespective of the cage or test tube incubation vessel and release was much slower than observed in vivo for both drugs. Moreover, Tr-A and leuprolide pharmacokinetics with and without the cage were highly similar during the 2-3 week release duration before a significant inflammatory response was caused by the cage implant. Hence, the PK-validated cage implant provides a simple means to recover and evaluate the microsphere drug carriers in vivo during a time window of at least a few weeks in order to characterize the polymer microsphere release and erosion behavior in vivo. This approach may facilitate development of mechanism-based in vitro/in vivo correlations and enable development of more accurate and useful in vitro release tests.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cage model; Controlled release; IVIVC; PLGA; Release kinetics

Mesh:

Substances:

Year:  2016        PMID: 27693924     DOI: 10.1016/j.biomaterials.2016.07.041

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

1.  Full-Spectrum Cannabis Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect.

Authors:  Almog Uziel; Anat Gelfand; Keren Amsalem; Paula Berman; Gil M Lewitus; David Meiri; Dan Y Lewitus
Journal:  ACS Appl Mater Interfaces       Date:  2020-05-15       Impact factor: 9.229

Review 2.  FDA's Poly (Lactic-Co-Glycolic Acid) Research Program and Regulatory Outcomes.

Authors:  Yan Wang; Bin Qin; Grace Xia; Stephanie H Choi
Journal:  AAPS J       Date:  2021-06-29       Impact factor: 4.009

Review 3.  Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development.

Authors:  Yi Wen Lim; Wen Siang Tan; Kok Lian Ho; Abdul Razak Mariatulqabtiah; Noor Hayaty Abu Kasim; Noorsaadah Abd Rahman; Tin Wui Wong; Chin Fei Chee
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.